Current Guidelines for the Management of Aggressive Non-Hodgkin’s Lymphoma

[1] Weisenburger DD(1994)Epidemiology of non-Hodgkin’s lymphoma: recent findings regarding an emerging epidemic Ann Oncol 5 19-24

[2] Lee Harris N(1982)summary and description of a working formulation of clinical usage Cancer 49 2112-35

[3] Jaffe ES(1994)A revised European-American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group Blood 84 1361-92

[4] Stein H(1996)Lymphoma classification: the gap between biology and clinical management is closing Blood 88 4085-9

[5] Hiddeman W(1993)A predictive model for aggressive NHL: the international non-Hodgkins lymphoma factors project N Engl J Med 329 987-94

[6] Longo DL(1971)Report of the committee on Hodgkin’s disease staging classification Cancer Res 31 1860-1

[7] Coiffier B(1975)Advanced diffuse histiocytic lymphoma, a potentially curable disease Lancet I 248-50

[8] Shipp MA(1985)Diffuse aggressive lymphoma: increased survival after alternating flexible sequences of Pro MACE and MOPP chemotherapy Ann Intern Med 98 304-9

[9] Harrington DP(1990)The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen J Clin Oncol 8 84-93

[10] Anderson JR(1988)The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma Semin Hematol 25 22-33

[1] Weisenburger DD(1994)Epidemiology of non-Hodgkin’s lymphoma: recent findings regarding an emerging epidemic Ann Oncol 5 19-24

[2] Lee Harris N(1982)summary and description of a working formulation of clinical usage Cancer 49 2112-35

[3] Jaffe ES(1994)A revised European-American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group Blood 84 1361-92

[4] Stein H(1996)Lymphoma classification: the gap between biology and clinical management is closing Blood 88 4085-9

[5] Hiddeman W(1993)A predictive model for aggressive NHL: the international non-Hodgkins lymphoma factors project N Engl J Med 329 987-94

[6] Longo DL(1971)Report of the committee on Hodgkin’s disease staging classification Cancer Res 31 1860-1

[7] Coiffier B(1975)Advanced diffuse histiocytic lymphoma, a potentially curable disease Lancet I 248-50

[8] Shipp MA(1985)Diffuse aggressive lymphoma: increased survival after alternating flexible sequences of Pro MACE and MOPP chemotherapy Ann Intern Med 98 304-9

[9] Harrington DP(1990)The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen J Clin Oncol 8 84-93

[10] Anderson JR(1988)The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma Semin Hematol 25 22-33